201 related articles for article (PubMed ID: 9457225)
1. Effect of thromboxane synthetase inhibitor on non-heart-beating donors in rat orthotopic liver transplantation.
Soejima Y; Yanaga K; Nisizaki T; Yoshizumi T; Uchiyama H; Sugimachi K
Surgery; 1998 Jan; 123(1):67-72. PubMed ID: 9457225
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of FK506 and thromboxane synthase inhibitor on ischemia-reperfusion injury in non-heart-beating donor in rat orthotopic liver transplantation.
Sasaki K; Miyake H; Kinoshita T; Ikeyama S; Tashiro S
J Med Invest; 2004 Feb; 51(1-2):76-83. PubMed ID: 15000260
[TBL] [Abstract][Full Text] [Related]
3. The effects of thromboxane A2 synthetase inhibitor (OKY-046) on complete hepatic ischemia in rats with obstructive jaundice.
Takahashi T
Surg Today; 1996; 26(1):15-20. PubMed ID: 8680115
[TBL] [Abstract][Full Text] [Related]
4. The protective effect of thromboxane A2 synthetase inhibitor against ischemic liver injury.
Isozaki H; Okajima K; Hara H; Kobayashi M
Surg Today; 1994; 24(5):435-40. PubMed ID: 8054815
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the thromboxane A2 synthetase inhibitor OKY-046 in a warm ischemia-reperfusion rat model.
Garvin PJ; Niehoff ML; Robinson SM; Heisler T; Salinas-Madrigal L; Contis J; Solomon H
Transplantation; 1996 May; 61(10):1429-34. PubMed ID: 8633364
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic analysis of post-reperfusion syndrome and the effect of preventing this syndrome using thromboxane A2 synthetase inhibitor (OKY-046) in swine liver transplantation.
Ishine N; Yagi T; Ishikawa T; Sasaki H; Nakagawa K; Tanaka N
Transplant Proc; 1997; 29(1-2):378-81. PubMed ID: 9123045
[No Abstract] [Full Text] [Related]
7. Liberation of vasoactive substances and its prevention with thromboxane A2 synthase inhibitor in pig liver transplantation.
Yokoyama I; Kobayashi T; Negita M; Hayashi S; Yasutomi M; Katayama A; Uchida K; Takagi H
Transpl Int; 1996; 9(1):76-81. PubMed ID: 8748415
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of TXA synthesis with OKY-046 improves liver preservation by prolonged hypothermic machine perfusion in rats.
Xu H; Lee CY; Clemens MG; Zhang JX
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e212-20. PubMed ID: 17645480
[TBL] [Abstract][Full Text] [Related]
9. Involvement of thromboxane A2-thromboxane A2 receptor system of the hepatic sinusoid in pathogenesis of cold preservation/reperfusion injury in the rat liver graft.
Ishiguro S; Arii S; Monden K; Fujita S; Nakamura T; Niwano M; Harada T; Ushikubi F; Narumiya S; Imamura M
Transplantation; 1995 Apr; 59(7):957-61. PubMed ID: 7709455
[TBL] [Abstract][Full Text] [Related]
10. The combined use of prostaglandin I2 analogue (OP-2507) and thromboxane A2 synthetase inhibitor (OKY-046) strongly inhibits atherosclerosis of aortic allografts in rats.
Hirano T; Nakafusa Y; Kawano R; Motoyama K; Arima T; Sugitani A; Tanaka M
Surgery; 2001 May; 129(5):595-605. PubMed ID: 11331452
[TBL] [Abstract][Full Text] [Related]
11. Endothelin antagonist treatment for successful liver transplantation from non-heart-beating donors.
Fukunaga K; Takada Y; Taniguchi H; Mei G; Seino KI; Yuzawa K; Otsuka M; Todoroki T; Goto K; Fukao K
Transplantation; 1999 Jan; 67(2):328-32. PubMed ID: 10075603
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effect of thromboxane A2 synthetase inhibitor on cold-stored rat liver.
Suehiro T; Yanaga K; Itasaka H; Kishikawa K; Shirabe K; Sugimachi K
Transplantation; 1994 Oct; 58(7):768-73. PubMed ID: 7940709
[TBL] [Abstract][Full Text] [Related]
13. Organ preserving effect of lidocaine administration in the model of orthotopic liver transplantation from non-heart-beating donors.
Kusano T; Shiraishi M; Miyaguni T; Hara J; Muto Y
Transplant Proc; 1996 Jun; 28(3):1928-9. PubMed ID: 8658950
[No Abstract] [Full Text] [Related]
14. Protective effects of L-arginine against ischemia-reperfusion injury in non-heart beating rat liver graft.
Gong J; Lao XJ; Zhang SJ; Chen S
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):481-4. PubMed ID: 18842493
[TBL] [Abstract][Full Text] [Related]
15. Effects of thromboxane A2 synthesis inhibitor (OKY-046) on total liver ischemia in rats.
Kobayashi T; Esato K; Morita N; Noshima NS
Int Surg; 1996; 81(2):115-8. PubMed ID: 8912073
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of thromboxane A2 activity during warm ischemia of the liver.
Shirabe K; Kin S; Shinagawa Y; Chen S; Payne WD; Sugimachi K
J Surg Res; 1996 Feb; 61(1):103-7. PubMed ID: 8769950
[TBL] [Abstract][Full Text] [Related]
17. Effect of thromboxane A2 synthetase inhibitor on metabolism and contractility in ischemic reperfused rabbit heart.
Kawabata H; Ryomoto T; Katori R
Angiology; 1997 Aug; 48(8):689-97. PubMed ID: 9269138
[TBL] [Abstract][Full Text] [Related]
18. Experimental study of a type 3 phosphodiesterase inhibitor on liver graft function.
Ikegami T; Nishizaki T; Hiroshige S; Ohta R; Yanaga K; Sugimachi K
Br J Surg; 2001 Jan; 88(1):59-64. PubMed ID: 11136311
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effect of donor pretreatment with thromboxane A2 synthase inhibitor on the graft survival in pig liver transplantation.
Yokoyama I; Negita M; Kobayashi T; Hayashi S; Hachisuka T; Sato E; Orihara A; Uchida K; Takagi H
J Surg Res; 1996 Jan; 60(1):232-8. PubMed ID: 8592420
[TBL] [Abstract][Full Text] [Related]
20. Thromboxane A2 in preservation-reperfusion injury: the effect of thromboxane A2 synthetase inhibitor.
Suehiro T; Yanaga K; Itasaka H; Kishikawa K; Shirbe K; Shimada M; Sugimachi K
J Surg Res; 1996 May; 62(2):216-23. PubMed ID: 8632642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
